FDA OKs New Drug To Boost #COVID19 Protection for Immunocompromised People
"People with severely compromised immune systems may need regular infusions."
"#Pemgarda, made by the company Invivyd, is a successor to the previous monoclonal antibody #Evusheld, which was withdrawn from use by the FDA in January of 2023 when it became clear that it was not effective against new COVID-19 variants."
#Covid19: A British #Immunocompromised
woman who shielded for 2.5 years has spent more than £2,000 buying a drug privately to improve her immunity
#Evusheld is available in 32 countries but not in UK’s #NHS
“This is completely unacceptable to patients”
According to NIH, 91% of #Covid19 in the USA is resistant to EvuSheld. So #EvuSheld no longer protects immunocompromised patients.
See here: https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-evusheld/
Please boost so other folks can learn about this.
This sucks.
#Pandemic #CovidIsNotOver #SARSCoV2 #CovidTreatments #Disabled
[email protected]
@disability
@NIH admits "Due to the high prevalence of resistant Omicron subvariants" in U.S. #EvuSheld "is unlikely to be effective at preventing COVID-19 in the vast majority of individuals'
https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-evusheld/
https://twitter.com/mattbc/status/1612916135497703447?s=20&t=enbZWsAdGb_d3X8-srDF1w
AstraZeneca’s preventative COVID treatment likely not effective against XBB.1.5
The Food and Drug Administration (FDA) said on Friday that AstraZeneca’s preventative monoclonal antibody treatment for COVID-19 is likely ineffective against the XBB.1.5 omicron subvariant due to its similarity to other mutations of the virus that are also not neutralized by the treatment. In a statement, the FDA said it “does not anticipate that Evusheld…
Via the San Francisco Chronicle
The FDA issued a warning to
immunocompromised Americans Friday,
stating it does not anticipate that the
drug Evusheld will neutralize XBB.1.5,
the COVID omicron subvariant that is
currently estimated to account for 28%
of circulating variants in the U.S.
'500,000 immunocompromised people with little or no protection from vaccines need access to regular antibody treatment. Unlike in >30 other countries, UK govt refuses to make #Evusheld available on the NHS, citing insufficient data, despite fierce opposition from clinicians.' pic.twitter.com/QNn8wduTxL
Bass #Antifa #EcoHumanist
Vivienne Dunstan
Monica Di, PhD 
Paul Belcher 🇪🇺🇬🇧🇪🇸
The Bird
fritzoids
Ginny Mooy
genXcrone (she/her)
Joe Pajak (Dr)